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The major cause of acquired immune deficiency syndrome (AIDS) is human immunodeficiency
virus type 1 (HIV-1). We have been using evolutionary comparisons to trace (i) the origin(s) of
HIV-1 and (ii) the origin(s) of AIDS. The closest relatives of HIV-1 are simian immunodeficiency
viruses (SIVs) infecting wild-living chimpanzees (Pan troglodytes troglodytes) and gorillas (Gorilla gor-
illa gorilla) in west central Africa. Phylogenetic analyses have revealed the origins of HIV-1:
chimpanzees were the original hosts of this clade of viruses; four lineages of HIV-1 have arisen
by independent cross-species transmissions to humans and one or two of those transmissions
may have been via gorillas. However, SIVs are primarily monkey viruses: more than 40 species of
African monkeys are infected with their own, species-specific, SIV and in at least some host species,
the infection seems non-pathogenic. Chimpanzees acquired from monkeys two distinct forms of
SIVs that recombined to produce a virus with a unique genome structure. We have found that
SIV infection causes CD4þ T-cell depletion and increases mortality in wild chimpanzees, and so
the origin of AIDS is more ancient than the origin of HIV-1. Tracing the genetic changes that
occurred as monkey viruses adapted to infect first chimpanzees and then humans may provide
insights into the causes of the pathogenicity of these viruses.
Keywords: human immunodeficiency virus type 1; simian immunodeficiency virus; chimpanzee;
gorilla; adaptation; tetherin1. INTRODUCTION
The acquired immune deficiency syndrome (AIDS)
was first formally recognized in patients in the USA
in 1981. Subsequent characterization of the principal
causative agent, human immunodeficiency virus type
1 (HIV-1), revealed that it was a retrovirus. As strains
of HIV-1 were sampled from around the world, it
became apparent that they exhibit extremely high gen-
etic heterogeneity and that analysis of the evolution of
this diversity can reveal insights into the prehistory of
the virus (Sharp et al. 2001). HIV-1 strains can be
divided into three distinct groups, which have very
different prevalences. Groups N and O are rare, and
largely restricted to Cameroon and surrounding
countries. The vast majority (perhaps 98%) of HIV
infections worldwide are caused by HIV-1 group
M. Even within group M, there is very high diversity
and the epicentre of that diversity is in Africa and in
particular Kinshasa in the Democratic Republic of
Congo (Vidal et al. 2000). While HIV-1 has an extre-
mely fast rate of evolution, the virus must have
circulated within human populations for many years
before it was first recognized for this extent of diversity
to have accumulated. Using molecular clocks, the
common ancestor of HIV-1 group M strains has
been dated to around the 1920s (Korber et al. 2000;r for correspondence (paul.sharp@ed.ac.uk).
tribution of 18 to a Discussion Meeting Issue ‘Genetics and
es of evolution: 150 years of progress since Darwin’.
2487Worobey et al. 2008). Partial characterization (Zhu
et al. 1998; Worobey et al. 2008) of two viruses from
samples initially obtained around 1960 in Kinshasa
(then called Leopoldville) has shown that HIV-1
group M had already diversified substantially by that
time, corroborating this time scale, and pointing to
the location of the early diversification of these viruses
(Sharp & Hahn 2008).
At the time when HIV-1 was first described, the
closest known relative was visna, a virus from sheep
that is the prototypic member of the genus Lentivirus.
Additional lentiviruses were soon found in other
primates, and a second virus (HIV-2) was found
infecting humans. The viruses from non-human pri-
mates were termed simian immunodeficiency viruses
(SIVs). Among the first species to be found to be natu-
rally infected were African green monkeys (Chlorocebus
species), where the prevalence of infection is high
(greater than 50% of adults) and natural infections
appear to be non-pathogenic. The number of different
SIVs identified has increased steadily over the past
20 years. Currently, around 40 different primate
species have been found to harbour SIVs, though
information regarding prevalence and pathogenicity
is lacking for most. So far, SIVs have only been
found naturally infecting primates in sub-Saharan
Africa, though the extent to which Asian or new
world primates have been surveyed is unclear. Where
multiple strains of SIVs have been characterized from
a single species, they generally form a monophyletic
clade, indicating that the great majority ofThis journal is # 2010 The Royal Society
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a whole, including HIV-1 and HIV-2, form a distinct
clade within the lentiviruses, indicating that humans
acquired their infections from other primates (Bailes
et al. 2002). Phylogenetic analyses of these primate
lentiviruses have provided remarkably detailed insights
into the evolutionary origins of the human viruses.2. THE ORIGINS OF HIV-1 AND HIV-2
The origin of HIV-2 was resolved first. HIV-2 was first
found, and is still most common, among individuals
from west Africa. In 1989, a closely related SIV was
found in a monkey, the sooty mangabey (Cercocebus
atys), whose natural range is in west Africa (Hirsch
et al. 1989). Other examples of this virus, termed
SIVsmm, were soon found in other captive sooty man-
gabeys, and then in individuals from the wild (Chen
et al. 1996; Santiago et al. 2005). Closely related
viruses found in captive macaques cause severe
AIDS-like illness (Letvin et al. 1985), but SIV has
not been found in wild macaques (which are Asian pri-
mates), and SIVsmm seems to be non-pathogenic in
its natural host (Santiago et al. 2005; Keele et al.
2009). It soon became apparent that SIVsmm had
been inadvertently transmitted to various macaque
species in captivity (reviewed in Apetrei et al. 2005).
In phylogenetic analyses, HIV-2 strains can be divided
into various groups, which are interspersed among the
SIVsmm lineages (Gao et al. 1992, 1994). These
observations led to a rapid acceptance that sooty man-
gabeys were the source of HIV-2, and the interspersion
of HIV-2 strains among the SIVsmm lineages implied
that there had been multiple mangabey-to-human
cross-species jumps (Hahn et al. 2000). Only two of
these transmission events, leading to groups A and
B, have given rise to viruses that have spread widely
in the human population; six other lineages are each
known only from viruses found in single individuals
(Damond et al. 2004).
A virus closely related to HIV-1 was also first
reported in 1989; this virus, SIVcpz, was found in
two captive chimpanzees (Pan troglodytes) in Gabon
(Peeters et al. 1989; Huet et al. 1990). However, for
many years, chimpanzees were not accepted as the
source of HIV-1 because it remained unclear whether
wild chimpanzees are naturally infected with this
virus. Over the next 10 years, many (probably more
than a thousand) other chimpanzees were tested but
only a single further example of SIVcpz was found,
in a chimpanzee illegally imported to Belgium from
Kinshasa (Peeters et al. 1992). Furthermore, this
third example of SIVcpz was more divergent from
the previous examples than might be expected for
two viruses from a single host species (Vanden
Haesevelde et al. 1996). Thus, it appeared that SIV
was extremely rare in chimpanzees, and it seemed
possible that both chimpanzees and humans had
been infected from some other source(s), presumably
some monkey species in central Africa.
In 1999, we found a fourth example of SIV from
a chimpanzee. This ape was wild-caught and
imported to the USA, but records of its geographical
origin were not available. Chimpanzees havePhil. Trans. R. Soc. B (2010)traditionally been divided into several subspecies
(Groves 2001). Analyses of mitochondrial DNA
(mtDNA) indicate four subspecies: western (Pan
troglodytes verus), Nigerian (Pan t. ellioti), central
(P. t. troglodytes) and eastern (Pan t. schweinfurthii)
chimpanzees (Gagneux et al. 1999), which have non-
overlapping ranges across western and central Africa
(figure 1). (Note that P. t. ellioti was formerly termed
P. t. vellerosus; Oates et al. 2009.) From mtDNA
sequence analyses, we found that the two chimpanzees
from Gabon were (as expected) P. t. troglodytes, as was
the ape from the USA, while the other individual
belonged to P. t. schweinfurthii (Gao et al. 1999). In
contrast, it seemed likely that the vast majority of
chimpanzees that had tested negative for SIVs were
P. t. verus; this was subsequently confirmed (Prince
et al. 2002; Switzer et al. 2005). Thus, the apparent
scarcity of SIVs in chimpanzees could be explained
by an absence of infection in the one subspecies that
had been subject to the most testing. Indeed, two
additional examples of SIVcpz from P. t. troglodytes
were soon reported (Corbet et al. 2000).
The SIVcpz strains from P. t. troglodytes individuals
formed a monophyletic cluster with all HIV-1 strains,
with the single SIV from a P. t. schweinfurthii ape form-
ing an outgroup. All subsequently characterized
SIVcpz strains have conformed to this host sub-
species-specific clustering, and this explained the
unusually high level of divergence between the isolates
from Gabon and Belgium. These observations
implicated one particular chimpanzee subspecies,
P. t. troglodytes, as the source of the human viruses
(Gao et al. 1999). Since the various HIV-1 groups
are interspersed among the SIVcpz lineages, each
must have had a separate origin (figure 2).
Before 2002, all SIVs were isolated from blood or
tissue samples. This severely limited the extent to
which rare and endangered primate species could be
tested for more SIV strains, and in particular
prevented estimation of the prevalence of SIVs in wild
chimpanzee populations. Therefore, we developed an
approach for non-invasive screening of wild primates,
using faecal samples; from these, we are able to detect
antibodies against SIVs and obtain nucleotide
sequences from both the host and the virus (Santiago
et al. 2002). The species and subspecies, as well as
the sex and identity, of the host can be established
from mtDNA and various nuclear DNA markers,
respectively. Using this non-invasive sampling tech-
nique, we have been able to show that SIVcpz
infection is quite common and widespread among
both central and eastern chimpanzees (Santiago et al.
2003; Worobey et al. 2004; Keele et al. 2006, 2009;
Van Heuverswyn et al. 2007). However, the prevalence
is patchy: in some areas, around one-third of individuals
are infected, whereas in other areas the virus appears to
be absent. These surveys have finally established that
chimpanzees are indeed the natural reservoir for
SIVcpz and the source of HIV-1, and have also sup-
ported the contention that P. t. verus, and in addition
P. t. ellioti, are not infected with SIVs.
Initial phylogenetic analyses of the viral sequences
obtained by non-invasive sampling revealed two
key points (Keele et al. 2006). First, among the
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Figure 1. Map of west and central Africa, showing the ranges of chimpanzee subspecies (colour coded). The ranges of western
lowland gorillas (G. gorilla) and eastern Grauer’s gorillas (G. beringei) are superimposed. The gold circle denotes the region in
southeast Cameroon where SIVcpz strains closely related to HIV-1 group M are found.
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Figure 2. Origins of HIV-1. The phylogenetic relationships
among strains of SIVcpz (black from P. t. troglodytes, grey
from P. t. schweinfurthii), SIVgor (blue) and HIV-1 (red).
The red crosses mark four branches on which cross-species
jumps to humans occurred; the two blue crosses indicate
alternative possible branches on which a chimpanzee-
to-gorilla transmission occurred. The HIV-1 strains fall
into three groups (M, N and O; only two representatives of
each group are shown), and a recently described fourth lin-
eage (RBF168). Adapted from trees shown in Takehisa
et al. (2009) and Plantier et al. (2009).
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Phil. Trans. R. Soc. B (2010)newly described viruses were two clades of strains
extremely closely related to HIV-1 groups M and N,
respectively (figure 2). Second, the strains of SIVcpz
displayed phylogeographic clustering; that is, multiple
strains obtained from any one location formed mono-
phyletic clusters, while sample sites separated by
geographical barriers (typically large rivers) either
were discordant with regard to the presence or absence
of SIV infections, or featured strains of SIVs that were
not especially closely related. This observation
strongly suggests that the transmissions from chimpan-
zee to human that gave rise to groups M and N most
probably occurred in the locations where the closely
related SIVcpz strains were found. In particular,
these analyses pinpoint the probable source of the
viruses that gave rise to the HIV-1 group M pandemic
as being chimpanzees in the extreme southeast corner
of Cameroon (figure 1), in an area flanked by the
Boumba, Ngoko and Sangha rivers (Keele et al. 2006).
While HIV-1 group O also falls within the radiation
of SIVcpz strains, none of the chimpanzee viruses were
particularly closely related to HIV-1 group O. Further
analyses of ape faecal samples from across Cameroon
revealed group O-related viruses in gorillas (Gorilla
gorilla gorilla) (Van Heuverswyn et al. 2006; Takehisa
et al. 2009). Very recently, Plantier et al. (2009) have
reported an HIV-1 strain that does not fall within
any of the three described groups, and so must rep-
resent a fourth cross-species transmission; if viruses
from this lineage are found in other individuals, they
will constitute a fourth group, P. This new strain of
HIV-1 is very closely related to the gorilla viruses
(SIVgor), and has most probably resulted from
gorilla-to-human transmission. At present, it is unclear
whether gorillas were also the immediate source of
HIV-1 group O, or whether chimpanzee viruses were
transmitted in parallel to gorillas and humans
(figure 2).
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Figure 3. Mosaic structure of the SIVcpz genome. Boxes denote the long terminal repeat (LTR) regions and nine genes (tat
and rev each have two exons). The SIVcpz genome arose through recombination; regions in light and dark grey were derived
from the SIVrcm and SIVgsn/SIVmus/SIVmon lineages, respectively (the origin of the 50 exons of tat and rev is difficult to
determine).
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The conclusion that HIV-1 was derived from a virus
infecting chimpanzees is particularly interesting,
because chimpanzees and humans are so closely
related. This raises a number of questions, such as
the origin of the chimpanzee virus, whether adaptation
of SIVcpz to infecting chimpanzees rendered the virus
more capable of infecting humans and whether SIVcpz
infection of chimpanzees is pathogenic.
SIVagm infections of African green monkeys and
SIVsmm infections of sooty mangabeys appear to be
non-pathogenic (Silvestri 2008). Extrapolating from
this, it has been generally assumed that all natural
SIV infections, including that of chimpanzees, are
harmless. If true, the origin of AIDS coincided with
the origin of HIV. However, we have recently reported
evidence that contradicts this (Keele et al. 2009). The
SIV infection status of two habituated communities of
chimpanzees at Gombe National Park in Tanzania has
been studied since 2001 (Santiago et al. 2002). From
more than 550 chimpanzee-years of observations, we
found that SIV infection was associated with a 10- to
16-fold increase in age-corrected risk of death. It was
also found that fertility was significantly reduced in
SIV-positive females, both in terms of their birth rate
and the survival of their offspring. The primary symp-
tom of AIDS in humans is a reduction in the number
of CD4þ T-cells; the depletion of these cells reduces
host defences against secondary infections. It was
possible to determine CD4þ T-cell counts for five
deceased chimpanzees. Tissues from three SIV-posi-
tive chimpanzees had significantly lower counts than
those from two SIV-negative individuals. Two of the
three SIV-positive individuals had died of trauma-
related causes, while the third had no obvious injuries
but displayed weakness and lethargy; this third chim-
panzee had the lowest CD4þ T-cell counts and tissue
samples from this individual closely resembled the
histopathology of human end-stage AIDS patients
(Keele et al. 2009). While it has only so far been poss-
ible to assess the pathogenicity of SIVcpz at Gombe,
where the apes are eastern chimpanzees (figure 1),
there is no reason to believe that SIVcpz infection of
central chimpanzees differs in any substantial way.
These observations strongly suggest that SIVcpz infec-
tions in wild chimpanzees have a very similar effect to
HIV-1 infections of humans.
Since most SIVs infect monkey species, whereas
chimpanzees (like humans) are apes, it has always
seemed likely that chimpanzees initially acquired
SIVs from monkeys. However, none of the monkey
SIVs described prior to 2001 were especially closelyPhil. Trans. R. Soc. B (2010)related to SIVcpz. When SIVrcm was found in red-
capped mangabeys (Cercocebus torquatus), it was
noted that the 50 half of the genome was most similar
to SIVcpz (Beer et al. 2001). Soon after, a virus
(SIVgsn) was found in greater spot-nosed monkeys
(Cercopithecus nictitans), where the 30 half of the
genome was most similar to SIVcpz (Courgnaud
et al. 2002). Both SIVrcm and SIVgsn were interpreted
as being recombinants between SIVcpz and other, as
yet unidentified, SIV lineages. However, we showed
that it is more likely that SIVcpz arose from recombi-
nation between the SIVrcm and SIVgsn lineages
(Bailes et al. 2003), obviating the need to invoke
other unknown SIVs. Subsequently, viruses (SIVmus
and SIVmon) closely related to SIVgsn were found
in mustached guenons (Cercopithecus cephus) and
mona monkeys (Cercopithecus mona) (Courgnaud
et al. 2003), and it can be seen that it was an ancestor
of these three SIVs that was involved in the recombina-
tion event that generated SIVcpz (Sharp et al. 2005).
Thus, it appears that chimpanzees acquired SIVs
from two different species of monkeys, most probably
by predation. The current ranges of red-capped man-
gabeys and the relevant Cercopithecus species overlap
that of P. t. troglodytes in west central Africa (Groves
2001), and so it appears likely that this subspecies
was first infected. The two monkey viruses then
recombined, and this mosaic spread to become the
only form now found in chimpanzees, and the ancestor
of HIV-1 and SIVgor.
This recombinant virus has a genome structure
unique among the SIVs (figure 3). First, it has a vpu
gene overlapping the 50 end of the env gene. This
vpu gene is not present in the genomes of most
monkey SIVs (including SIVrcm), but is found in
viruses from the lineage including SIVgsn, SIVmus
and SIVmon. Second, while in most SIV genomes
there is a short overlap between the 30 end of the env
gene and the 50 end of the nef gene, in SIVcpz there
is none. This region has been duplicated in SIVcpz,
presumably during the recombination event, because
each of the duplicate copies was derived from a
different parental virus (Schindler et al. 2006).
It has been found that most SIVs, and in particular
those for which there is the best evidence of non-
pathogenicity in the natural host (SIVsmm and
SIVagm), encode a Nef protein that downregulates
the T-cell receptor CD3 and thereby suppresses
T-cell activation; in contrast, the Nef protein of
SIVcpz, like that of HIV-1, does not downregulate
CD3 (Schindler et al. 2006). This is surprising because
the nef gene of SIVcpz was derived from the SIVrcm
Review. Evolution of HIV-1 and origin of AIDS P. M. Sharp & B. H. Hahn 2491lineage (figure 3) and SIVrcm Nef does downregulate
CD3 (Schindler et al. 2006); thus, the Nef protein of
SIVcpz has lost this activity. Since high-level immune
activation is associated with progression to AIDS,
this change in the properties of SIVcpz Nef correlates
with pathogenicity. It is not known whether SIVgsn,
SIVmus or SIVmon are pathogenic in their natural
hosts. The Nef proteins of these viruses also do not
downregulate CD3, but since the nef gene of SIVcpz
was not acquired from the SIVgsn lineage, this
property must have evolved independently in SIVcpz.
The shared feature of the viruses that do not down-
regulate CD3 is the presence of a vpu gene, but it is
not clear why this might have prompted the nef gene
to evolve to lose this function.4. HOST ADAPTATION
HIVs and SIVs interact with many host proteins
(Bushman et al. 2009). Since many of those host pro-
teins have diverged since the common ancestor of Old
World monkeys and apes, it is likely that when chim-
panzees first acquired SIV, the virus had to adapt in
order to replicate efficiently and spread in its new
host. Chimpanzees and humans are genetically very
similar owing to their recent common ancestry,
but there is also evidence that differences between
chimpanzee and human proteins placed selection
pressures on SIVcpz after it jumped from chimpanzees
to humans.
Tetherin is a mammalian protein with a recently dis-
covered antiviral activity. Tetherin dimers appear to
form ‘tethers’ between virus envelopes and the cyto-
plasmic membrane of the cell, preventing the release
of those viruses (Neil et al. 2008). The Vpu protein
of HIV-1 has long been known to promote the release
of progeny virions, and it is now known that this is
mediated by antagonizing tetherin. However, as
described above, the vpu gene is present in only a
few SIV genomes. In SIVsmm and SIVagm, which
lack vpu genes, the Nef protein has anti-tetherin
activity (Jia et al. 2009; Zhang et al. 2009). Neverthe-
less, it was surprising to find that in SIVcpz, it is the
Nef protein, rather than the Vpu protein, that counter-
acts tetherin (Sauter et al. 2009). When SIVcpz was
formed by recombination, it acquired two genes with
potential anti-tetherin activity: a vpu gene from the
SIVgsn lineage and a nef gene from SIVrcm
(figure 3); the Vpu protein of SIVgsn has been
shown to counteract greater spot-nosed monkey
tetherin (Sauter et al. 2009), while the Nef protein of
SIVrcm is expected to function against mangabey
tetherin (although this has not yet been tested exper-
imentally). However, there is species specificity in
these interactions, reflecting divergence in the tetherin
sequences of different primates. Thus, when SIVs first
infected chimpanzees, it is likely that neither the Vpu
nor the Nef protein had full anti-tetherin activity; cer-
tainly Vpu proteins from contemporary SIVgsn,
SIVmon or SIVmus strains have no activity against
chimpanzee tetherin (Sauter et al. 2009). Vpu and
Nef antagonize tetherin through interactions with
different parts of the tetherin protein: for Vpu it is
the transmembrane (TM) region, and for Nef thePhil. Trans. R. Soc. B (2010)cytoplasmic tail (CT). In a comparison of monkey
and chimpanzee tetherin sequences, the CT is less
divergent than the TM and so this may be why the
Nef protein was better able to adapt.
Since SIVcpz uses the Nef protein to counteract
tetherin, it is surprising that HIV-1 uses Vpu.
However, human tetherin has diverged from the
chimpanzee protein, most notably owing to a deletion
of a pentamer within the CT. As a consequence, the
SIVcpz Nef protein is not active against human
tetherin (Sauter et al. 2009). Clearly, this would have
placed strong selection pressure on HIV-1, and this
has resulted in the reacquisition of an anti-tetherin
activity by Vpu. Perhaps the surprising aspect of this
is that, while the Vpu protein of SIVcpz was not
being constrained to retain anti-tetherin activity,
nevertheless the vpu gene did not diverge to the
extent that the activity could not be rescued.
Since the HIV-1 groups M, N and O each arose
through separate transmissions of SIVs from apes,
the selection pressure to counteract human tetherin
would have been exerted on three independent
occasions. This led to different outcomes. Only in
the case of HIV-1 group M has adaptation been fully
successful. In HIV-1 group O strains, neither Vpu
nor Nef efficiently antagonize human tetherin
(Sauter et al. 2009). HIV-1 group N Vpu has evolved
to become active against tetherin, but this appears to
have been at a cost. A second major function of Vpu
is to bind to CD4 to induce its degradation. Unlike
the anti-tetherin activity, this function seems to be
highly conserved and not species-specific, perhaps
because CD4 itself is less divergent among primates
than is tetherin. However, HIV-1 group N Vpu has
lost this anti-CD4 activity, possibly in the process of
adaptation to an anti-tetherin activity. In summary,
HIV-1 group M Vpu has two main functions: an
anti-CD4 activity that was conserved from SIVcpz,
and an anti-tetherin activity acquired since trans-
mission to humans. HIV-1 group N has lost the first
of these, while HIV-1 group O has not acquired the
second. It is tempting to speculate that these differ-
ences may at least partly explain why group N and O
viruses are quite rare, while group M viruses dominate
the global AIDS pandemic (Sauter et al. 2009).
An alternative approach to seeking signatures of
host-specific adaptation in HIV-1 is to look for similar
genetic changes that occurred independently on each
of the occasions when SIVs jumped into humans.
Comparing the sequences of SIVcpz with those of
the inferred ancestors of the three HIV-1 groups, we
found one site in the proteome that was well conserved
among SIVcpz but had changed, in the same way, on
each of the three host jumps giving rise to groups
M, N and O (Wain et al. 2007). Codon 30 of the gag
gene encodes Met in all known strains of SIVcpz
from central chimpanzees, and also in SIVgor.
However, the inferred ancestral sequences of the
three HIV-1 groups encode Arg at this position,
implying that a radical amino acid replacement
occurred on each of the three branches of the tree
encompassing cross-species transmission to humans.
Two lines of evidence provide corroboration that this
site is involved in host-species-specific adaptation.
2492 P. M. Sharp & B. H. Hahn Review. Evolution of HIV-1 and origin of AIDSThe first comes from an experiment in which a
chimpanzee was infected with HIV-1; when the virus
was sequenced 10 years later, this site had reverted
to encoding Met (Mwaengo & Novembre 1998). Sec-
ondly, this chimpanzee-adapted HIV-1 virus was
subjected to site-directed mutagenesis and then
tested for replication in chimpanzee and human
CD4þ T-cells. Viruses differing only at codon 30 of
gag grew with different efficiency in chimpanzee
T-cells, with those encoding Met replicating faster;
the opposite was observed in human T-cells (Wain
et al. 2007). This part of the gag gene encodes the
N-terminal domain of the matrix protein. The struc-
ture of this protein has been solved (Hill et al. 1996),
and while there is considerable information about the
interaction of the matrix protein with host proteins,
there is as yet no clue as to the function of this
particular residue or why chimpanzee and human
hosts exert different selection pressures on it.5. CONCLUSIONS
It has been possible to reconstruct a surprisingly
detailed picture of the origins of pandemic AIDS
(Sharp & Hahn 2008). The source of HIV-1 group
M, the main form of AIDS virus infecting humans,
has been traced to a virus infecting the central subspe-
cies of chimpanzees, P. t. troglodytes, in a remote area in
the southeast corner of Cameroon (Keele et al. 2006).
The likeliest route of chimpanzee-to-human trans-
mission would have been through exposure to
infected blood and body fluids during the butchery
of bushmeat (Hahn et al. 2000). The early diversifi-
cation of group M appears to have occurred some
700 km further south, in Kinshasa (then called
Leopoldville), in the early years of the twentieth
century (Worobey et al. 2008). The links between
these two regions are waterways, which were the
major communication routes at that time: the rivers
from southeast Cameroon flow south, ultimately
joining the Congo River on which Kinshasa is located.
Other viruses from central chimpanzees have been
transmitted to humans, giving rise to HIV-1 groups
N and O, and the prospective group P; among these,
some (probably P, and perhaps O) may have been
transmitted via gorillas. It is striking that all of these
transmissions were derived from one subspecies of
chimpanzee. Eastern chimpanzees also have SIVcpz,
but descendants of those viruses have not been
detected in humans, nor in gorillas that are sympatric
with eastern chimpanzees (Takehisa et al. 2009). It is
not clear that humans living in east central Africa are
less likely to have been exposed to SIVcpz than those
living in west central Africa. It is possible that the
level of surveillance has been lower in east central
Africa, and that rare strains of HIV-1 derived from
the SIVcpz of eastern chimpanzees circulate unde-
tected. Alternatively, given that it is clear that SIVcpz
of central chimpanzees has had to adapt in various
ways to spread in humans, it is possible that the diver-
gent form of SIVcpz found in eastern chimpanzees has
less potential to make these adaptations.
Considering HIV-1 and HIV-2 together, it appears
that there have been at least a dozen independentPhil. Trans. R. Soc. B (2010)transmissions of SIVs to humans. None of these
appear older than HIV-1 group M: the common
ancestor of HIV-1 group O has been dated to around
the same time (Lemey et al. 2004), while those of
HIV-2 groups A and B may have been a little more
recent (Lemey et al. 2003). The opportunities for
chimpanzee- or monkey-to-human host jumps have
existed for hundreds or thousands of years, and it
must be expected that many such transmissions
occurred in the past. However, only in the twentieth
century did such viruses spread to detectable levels
in the human population. In west central Africa
during the early part of that century, the destabiliza-
tion of social structures by invading colonial powers
(Chitnis et al. 2000), the origin and rapid growth of
major conurbations (Worobey et al. 2008) and the
widespread use of injections (Pepin & Labbe 2008)
may all have contributed to provide an unprecedented
opportunity for dissemination of blood-borne viruses.
The finding that HIV-1 originated in our closest
living relatives raises a number of issues. Gene
sequences of humans and chimpanzees typically
differ at less than 2 per cent of nucleotides. Despite
this genetic similarity of humans and chimpanzees, it
is apparent that SIVcpz was subject to pressures to
adapt to its new human host. It is clearly of substantial
interest to understand much more about the natural
biology of SIVcpz infection and transmission in chim-
panzees, and the extent to which the natural history of
these viruses differs from HIV-1 in humans. It will be
of particular interest to understand the extent to which
co-infection with other viruses, bacteria, protozoa
(such as Plasmodium) or multicellular eukaryotes
(e.g. worms) influence the course of SIVcpz infection
and pathogenesis. For example, there is some evidence
that humans co-infected with HIV-1 and GBV-C (a
seemingly non-pathogenic member of the Flaviviridae)
remain asymptomatic longer than those infected by
HIV-1 alone (Stapleton et al. 2004); close relatives of
GBV-C have been found in chimpanzees (Adams
et al. 1998; Birkenmeyer et al. 1998). Further compari-
sons of SIVcpz and HIV-1 infections may shed light
on the viral and host factors responsible for disease
progression and ultimately point the way to novel
therapeutic interventions.
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